Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?

Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids? Letters over different points of time. J Pediatr Hematol Oncol. 2018;40(2):e83-e90. the editorialist still recommends using low cumulative doses doi:10.1097/MPH.0000000000001060 (less than 2 mg/kg). 4. Brown K, Farmer C, Farhadian B, Hernandez J, Thienemann M, Frankovich J. Preventing BPD is crucial, given its respiratory and non- Pediatric acute-onset neuropsychiatric syndrome response to oral respiratory outcomes, and the use of corticosteroids in in- corticosteroid bursts: an observational study of patients in an academic fants at risk of BPD being treated with noninvasive ventila- community-based PANS clinic. J Child Adolesc Psychopharmacol. 2017;27(7): 629-639. doi:10.1089/cap.2016.0139 tion is, to our best knowledge, an as-yet unexplored field that 5. Leonard A, Godiwala N, Herrera N, McCarter R, Sharron M, Meier ER. Early deserves a closer look. It is likely that neonatologists will be initiation of inhaled corticosteroids does not decrease acute chest syndrome using this practice in the coming years. morbidity in pediatric patients with sickle cell disease. Blood Cells Mol Dis. 2018; 71:55-62. doi:10.1016/j.bcmd.2018.03.001 Luca Bonadies, MD, PhD 6. Kimura Y, Grevich S, Beukelman T, et al; CARRA Registry Investigators. Pilot Daniel Nardo, MD study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic juvenile idiopathic arthritis consensus treatment plans. Eugenio Baraldi, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Pediatrics American Medical Association

Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?

JAMA Pediatrics , Volume 175 (10) – Oct 6, 2021

Loading next page...
 
/lp/american-medical-association/is-a-new-era-coming-for-bronchopulmonary-dysplasia-prevention-with-joWpwwF03O

References (5)

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2168-6203
eISSN
2168-6211
DOI
10.1001/jamapediatrics.2021.1858
Publisher site
See Article on Publisher Site

Abstract

Letters over different points of time. J Pediatr Hematol Oncol. 2018;40(2):e83-e90. the editorialist still recommends using low cumulative doses doi:10.1097/MPH.0000000000001060 (less than 2 mg/kg). 4. Brown K, Farmer C, Farhadian B, Hernandez J, Thienemann M, Frankovich J. Preventing BPD is crucial, given its respiratory and non- Pediatric acute-onset neuropsychiatric syndrome response to oral respiratory outcomes, and the use of corticosteroids in in- corticosteroid bursts: an observational study of patients in an academic fants at risk of BPD being treated with noninvasive ventila- community-based PANS clinic. J Child Adolesc Psychopharmacol. 2017;27(7): 629-639. doi:10.1089/cap.2016.0139 tion is, to our best knowledge, an as-yet unexplored field that 5. Leonard A, Godiwala N, Herrera N, McCarter R, Sharron M, Meier ER. Early deserves a closer look. It is likely that neonatologists will be initiation of inhaled corticosteroids does not decrease acute chest syndrome using this practice in the coming years. morbidity in pediatric patients with sickle cell disease. Blood Cells Mol Dis. 2018; 71:55-62. doi:10.1016/j.bcmd.2018.03.001 Luca Bonadies, MD, PhD 6. Kimura Y, Grevich S, Beukelman T, et al; CARRA Registry Investigators. Pilot Daniel Nardo, MD study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic juvenile idiopathic arthritis consensus treatment plans. Eugenio Baraldi,

Journal

JAMA PediatricsAmerican Medical Association

Published: Oct 6, 2021

There are no references for this article.